Systane Complete Multi-symptom Relief

Status Completed

Clinical Trial Summary

The purpose of this study is to demonstrate effective symptom relief with the use of Systane Complete among subjects with dry eye disease (DED).

Clinical Trial Description

Subjects will be expected to attend a screening/baseline visit and one additional visit at Day 28 (± 2 days), with a telephone call visit conducted at Day 14 (± 2 days). Individual duration of subject participation will be approximately 28 days. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05056155
Study type	Interventional
Source	Alcon Research
Contact
Status	Completed
Phase	N/A
Start date	November 9, 2021
Completion date	March 25, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03216096` - Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease	Phase 1
Completed	`NCT05825599` - PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms	N/A
Completed	`NCT04656197` - The Ocular Microbiome in Patients With Dry Eye Disease
Completed	`NCT05031806` - Evaluation of the Safety, Tolerability and Efficacy of iNexin™ for the Treatment of the Signs and Symptoms Associated With Dry Eye Disease	Phase 1
Completed	`NCT03688802` - Efficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland Stimulation	Phase 2
Completed	`NCT05213156` - Concentration of Ofloxacin Into the Aqueous Humour of Patients With Dry Eye Disease	Phase 4
Completed	`NCT04548427` - Study to Evaluate the Efficacy and Safety of CKD-352	Phase 3
Completed	`NCT06176651` - Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers	Phase 4
Completed	`NCT02254265` - Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca	Phase 2/Phase 3
Completed	`NCT00395759` - The Visual Effect of an Investigational Artificial Tear in the Tear Layer.	N/A
Completed	`NCT00680108` - A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution	Phase 2
Recruiting	`NCT06064071` - Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD	N/A
Completed	`NCT04139122` - Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease	Phase 1/Phase 2
Not yet recruiting	`NCT06375343` - Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®	Phase 1
Completed	`NCT01468168` - A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients	Phase 2
Completed	`NCT01014078` - A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease	Phase 4
Completed	`NCT00799682` - Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®	Phase 4
Completed	`NCT05082974` - Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)	Phase 3
Recruiting	`NCT06146881` - Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia	Phase 2
Completed	`NCT03292809` - CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)	Phase 2/Phase 3